Fada Medical is an award-winning Irish Medtech startup that is dedicated to improving the delivery of insulin for people with Type 1 Diabetes. They are focused on developing an extended wear infusion set cannula, which is the most important component of the insulin pump system. The current infusion sets have a short lifespan of 2 or 3 days and often fail within hours of insertion, causing interruptions to insulin therapy and impacting blood-glucose control.

Fada Medical aims to address this unmet need and revolutionize insulin pump technology. Their innovative technology offers a longer lifespan of up to 30 days, which is 10 times longer than the current gold standard. This will result in more consistent insulin delivery and improved glucose control.

Fada Medical's infusion set cannula is also kink-resistant and resistant to silent occlusion, ensuring reliable insulin therapy for patients. By optimizing chronic drug therapy, starting with insulin delivery for type 1 diabetes, Fada Medical aims to make life easier for those in need. Their mission is to enhance patient outcomes, reduce healthcare waste, and eliminate the burden and unreliability associated with current infusion sets.

With a dedicated team of experts, Fada Medical is poised to transform the field of insulin therapy and improve the lives of individuals with type 1 diabetes